Scholarlink

Background <p>Multiple sclerosis (MS) results in histological alterations, which in turn leads to behavioral deficits. Bone marrow mesenchymal stem cells (BMSCs) demonstrate therapeutic potential in MS. This study aimed to assess whether intranasally delivered BMSCs improve cerebellar structure and motor function in an intermittent cuprizone-induced (INT-CPZ) MS model.&#xa0;</p> Methods <p>The mice were divided into five groups: control, CPZ, CPZ + BMSC, INT-CPZ, and INT-CPZ + BMSC. BMSCs were intranasally delivered at weeks 4 and 10. Motor performance was evaluated using beam walking, pole, and ladder rung walking tests. Stereological analyses were performed to estimate cortex and white matter volumes and Purkinje cell number.&#xa0;</p> Results <p>BMSC treatment improved motor coordination and balance, particularly in INT-CPZ + BMSC mice, which outperformed the CPZ + BMSC group. Stereological results showed reduced volume loss in cortex and white matter and higher Purkinje cell number in BMSC-treated groups, with INT-CPZ + BMSC showing the most pronounced effect.&#xa0;</p> Conclusion <p>Intranasal BMSC therapy effectively preserved cerebellar structure and motor function in cuprizone-exposed mice. Intermittent cuprizone exposure enhanced BMSC efficacy, likely through mechanisms involving neuroregeneration, and neuroprotection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bone marrow mesenchymal stem cells ameliorate intermittent multiple sclerosis: quantitative cerebellar microscopy and functional analysis in cuprizone-induced mice

  • 期刊论文

  • 发表日期：

    2026年2月6日

查看全文
  • Maedeh Hashemi,
  • Iraj Ragerdi Kashani,
  • Parichehr Pasbakhsh,
  • Babak Ebrahimi,
  • Shiva Amirizadeh,
  • Davood Zarini,
  • Mohammad Hassan Tajik,
  • Reza Asadi-Golshan

摘要

Background

Multiple sclerosis (MS) results in histological alterations, which in turn leads to behavioral deficits. Bone marrow mesenchymal stem cells (BMSCs) demonstrate therapeutic potential in MS. This study aimed to assess whether intranasally delivered BMSCs improve cerebellar structure and motor function in an intermittent cuprizone-induced (INT-CPZ) MS model. 

Methods

The mice were divided into five groups: control, CPZ, CPZ + BMSC, INT-CPZ, and INT-CPZ + BMSC. BMSCs were intranasally delivered at weeks 4 and 10. Motor performance was evaluated using beam walking, pole, and ladder rung walking tests. Stereological analyses were performed to estimate cortex and white matter volumes and Purkinje cell number. 

Results

BMSC treatment improved motor coordination and balance, particularly in INT-CPZ + BMSC mice, which outperformed the CPZ + BMSC group. Stereological results showed reduced volume loss in cortex and white matter and higher Purkinje cell number in BMSC-treated groups, with INT-CPZ + BMSC showing the most pronounced effect. 

Conclusion

Intranasal BMSC therapy effectively preserved cerebellar structure and motor function in cuprizone-exposed mice. Intermittent cuprizone exposure enhanced BMSC efficacy, likely through mechanisms involving neuroregeneration, and neuroprotection.